Market Tracker

04/23 6:05pm ET

Echo Therapeutics Inc (NASDAQ:ECTE)

3.20
Data as of Apr 23
 +0.02 / +0.63%
Today’s Change
1.84
Today|||52-Week Range
6.80
+1.91%
Year-to-Date

Today’s Trading

Previous close3.18
Today’s open3.18
Day’s range3.12 - 3.22
Volume47,174
Average volume (3 months)164,526
Market cap$37.6M
Dividend yield--
Data as of 3:59pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+55.15%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...-0.03-1.60%
ABIOARCA Biopharma Inc-0.04-2.31%
ENZNEnzon Pharmaceutical...+0.06+5.65%
SKBISkystar Bio-Pharmace...+0.19+3.12%
Data as of 3:59pm ET, 04/23/2014

Financials

Next reporting dateMay 9, 2014
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
Executive Chairman &
Chief Executive Officer
Robert F. Doman
Senior Vice President-
Operations
Marshall D. Deweese
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts